Clinical Epigenetics, the official journal of the Clinical Epigenetics Society, is an open access, peer-reviewed journal that encompasses all aspects of epigenetic principles and mechanisms in relation to human disease, diagnosis and therapy. Clinical trials and research in disease model organisms are particularly welcome. The journal is divided into the following sections:

  • Aging, development, imprinting and reproductive epigenetics
  • Allergy, immunology, pathogens and inflammation
  • Cancer epigenetics and diagnostics
  • Cardiovascular epigenetics
  • Endocrinology and metabolic disease
  • Epigenetic therapy and clinical trials
  • Innovative epigenetics therapies
  • Neurology and psychiatry
  • Nutritional and environmental epigenetics
  • All other subjects

For more information on the the section aims and scope visit our sections information page.


  • Ulrich Mahlknecht, St Lukas Clinic, Solingen

Reviews Editor

  • Marianne Rots, University Medical Center Groningen


There has been an error retrieving the data. Please try again.

Editor's profile

Ulrich Mahlknecht

Ulrich Mahlknecht
Ulrich Mahlknecht is currently a Professor of medicine at the University of Heidelberg, and Head of the Department of Hematology/Oncology at St. Lukas Clinic in Solingen, Germany.

His research focuses on novel targeted immunological and epigenetic concepts in the treatment of solid tumors and hematological malignancies.
Cancer and Obesity
Breakthroughs in Clinical Epigenetics series
Tissue specific DNA methylation profiles in new borns
Clinical Epigenetics blog

Society information

Clinical Epigenetics Society

The "Clinical Epigenetics Society" (CLEPSO) is a non-profit organization founded at Saarland University.

The society has five main objectives:

  •  Promotion and support of scientific research projects and initiatives within the field of clinical epigenetics.
  •  Promotion of the scientific exchange amongst its members.
  •  Encouragement and support of relations to national and international societies within the area of clinical and translational research.
  •  Development of an international research and scientific network within the field of clinical epigenetics.
  •  Providing a forum for encouraging discussions and contributions to the advancement of clinical epigenetics, through the Clinical Epigenetics journal, Blogs, scientific symposia, meetings, and newsletters.

Archival content

In October 2011, Clinical Epigenetics became a fully open access journal and is now published as part of BioMed Central's portfolio of journals. To view the journal's content prior to this transition, please see SpringerLink.

Join us on Facebook

Join the Clinical Epigenetics group on Facebook and keep up to date with the latest developments and discussions.
Submit a manuscript Sign up for article alerts Contact us Support

Email updates

Receive periodic news and updates relating to this journal straight to your inbox.

Indexed by

  • Academic OneFile
  • CAS
  • DOAJ
  • Journal Citation Reports/Science Edition
  • OCLC
  • PubMed
  • PubMed Central
  • Science Citation Index Expanded
  • Scopus
  • Summon by Serial Solutions

View all

ISSN: 1868-7083